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Abstract
Background: Musashi1 (Msi1) is an RNA binding protein with a central role during nervous
system development and stem cell maintenance. High levels of Msi1 have been reported in several
malignancies including brain tumors thereby associating Msi1 and cancer.
Methods: We used the human medulloblastoma cell line Daoy as model system in this study to
knock down the expression of Msi1 and determine the effects upon soft agar growth and
neurophere formation. Quantitative RT-PCR was conducted to evaluate the expression of cell
proliferation, differentiation and survival genes in Msi1 depleted Daoy cells.
Results: We observed that MSI1 expression was elevated in Daoy cells cultured as neurospheres
compared to those grown as monolayer. These data indicated that Msi1 might be involved in
regulating proliferation in cancer cells. Here we show that shRNA mediated Msi1 depletion in Daoy
cells notably impaired their ability to form colonies in soft agar and to grow as neurospheres in
culture. Moreover, differential expression of a group of Notch, Hedgehog and Wnt pathway related
genes including MYCN, FOS, NOTCH2, SMO, CDKN1A, CCND2, CCND1, and DKK1, was also found
in the Msi1 knockdown, demonstrating that Msi1 modulated the expression of a subset of cell
proliferation, differentiation and survival genes in Daoy.
Conclusion: Our data suggested that Msi1 may promote cancer cell proliferation and survival as
its loss seems to have a detrimental effect in the maintenance of medulloblastoma cancer cells. In
this regard, Msi1 might be a positive regulator of tumor progression and a potential target for
therapy.
Background
Musasi1 (Msi1) is an RNA binding protein essential dur-
ing nervous system development. It is considered a stem
cell marker whose expression has been found to be con-
served across species from fly to human [1]. In the mam-
malian postnatal brain, Msi1 is mainly expressed in cells
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that are believed to be the source of adult neural stem cells
[2] and seems to be critical for their maintenance and self-
renewal capability [1,3,4].
High levels of Msi1 have been reported in tumors such as
medulloblastoma [5,6], glioma [7,8], astrocytoma [9],
retinoblastoma [10] and colorectal adenoma [11].
Indeed, a correlation between high levels of Msi1 expres-
sion and poor prognosis has been proposed for glioma
and astrocytoma [8,9].
Two Msi1 direct targets have been characterized in mam-
mals: numb [12] and CDKN1A [13]. Binding of Msi1 to
specific motifs located in the 3' untranslated region (UTR)
of these mRNAs seems to interfere with translation,
thereby decreasing Numb and p21WAF (also known as
Cdkn1a) protein levels [12,13]. Numb is a regulator of
three important pathways usually deregulated in cancer:
Notch, Hedgehog and p53 (reviewed in [14-17]). Numb
represses Notch [18] and Hedgehog [19]. In addition,
Numb has recently been shown to prevent degradation of
the tumor suppressor p53 [20]. The second known target
of Msi1 is the cell cycle inhibitor p21WAF. Therefore, it is
plausible to surmise that by repressing translation of
Numb and p21WAF, high levels of Msi1 might promote
aberrant cell proliferation and failure in differentiation
and apoptosis.
We observed that the levels of MSI1 were elevated in Daoy
neurospheres (high proliferative cultures) compared to
monolayers (low proliferative cultures). This data sug-
gested a potential role for Msi1 in promoting cancer cell
proliferation in this medulloblastoma cell line. In order to
test this hypothesis, we depleted Msi1 in Daoy cells by
RNA interference. A significant reduction in soft agar
growth (in vitro indicator of tumorigenicity) and neuro-
sphere formation (surrogative measure of "stemness")
were observed. We also identified a set of cell proliferation
genes whose expression was significantly down-regulated
after Msi1 shRNA-mediated knockdown. Thus our data
suggested that Msi1 may promote cancer cell prolifera-
tion. We propose that Msi1 may maintain a pool of cancer
cells with deregulated proliferative capabilities which may
possibly serve as a source for future tumorigenic events. In
this regard, Msi1 might be a positive regulator of tumor
progression and a prospective target for therapeutic inter-
vention.
Methods
Cell lines, plasmids and transfections
Daoy cell line was obtained from American Type Culture
Collection (ATCC). Cells were cultured in improved min-
imum essential medium (IMEM) (Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal bovine serum
(Atlanta Biologicals, Inc., Lawrenceville, GA, USA). Msi1
was knocked down using a shRNAmir retroviral vector tar-
geting the sequence 5'-CGTCCTGTATCATATGTAAAT-3'
located in the 3'UTR of Msi1 mRNA (Oligo ID #
V2HS_280120; Open Biosystems). Cells were transfected
at 95% confluency using Lipofectamine2000 reagent (Inv-
itrogen) according to manufacturer's instructions. Stable
integration of the plasmid encoding the shRNA was
selected using 1 μg/mL of puromycin (InvivoGen, San
Diego, CA, USA). A stable Daoy cell line expressing a non-
silencing shRNAmir (Open Biosystems) was also gener-
ated as a negative control.
Musashi1 polyclonal antibody generation
A 174 nucleotide sequence encoding a 65 aminoacid
peptide unique for Msi1 (FPEFRVERTPLPSAPVLPEL
TAIPLTAYGPMAAAAAAAAVVRGTGSHPWTMAPPP
GSTLERPHRD) was cloned into pGEX-4T-1 (GE
Healthcare, Piscataway, NJ, USA) to generate a GST-
Msi1 fusion protein. GST-Msi1 recombinant protein
was purified to >90% homogeneity using Glutath-
ione Sepharose 4B (GE Healthcare) according to
manufacturer's instructions. Antibodies raised
against Msi1 were affinity-purified from the rabbit
antisera by column chromatography in two steps:
first using the antigen (GST-Msi1 protein) and then
using the GST purified protein. The antibodies were
eluted in PBS containing 0.01% of sodium azide and
stored at -80°C.
Western blotting
For western blot analysis cells were disrupted in lysis
buffer as described [45]. Equal amounts of protein extract
(50 μg per lane) were solubilized in 2× reducing sample
buffer (62.5 mM Tris-Hcl pH 6.8, 25% glycerol, 2% SDS,
0.1% w/v Orange G and 40 mM DTT), run on 12% Tris-
glycine SDS-Polyacrylamide gels and transferred to nitro-
cellulose membranes (Invitrogen) using a semi-dry trans-
blot system (Bio-Rad Laboratories, Inc., Hercules, CA,
USA). Membranes were stained with 0.1% w/v Ponceau
Red (Sigma-Aldrich, St Louis, MO, USA) solution,
blocked in 0.1% Tween 20/PBS containing 5% w/v non-
fat dry milk and incubated over night at 4°C with the
appropriated antibody; anti-βIII Tubulin (Abcam, Inc.,
Cambridge, MA, USA), anti-Bcl-2 (Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA, USA), anti-β-Actin (loading
control; Abcam) following manufacturers' guidelines, or
rabbit anti-Musashi1 polyclonal antibody (described
above) at a 0.5 μg/mL final concentration in blocking
buffer. After washing in 0.1% Tween 20/PBS, blots were
incubated for 1 hour at room temperature with goat anti-
rabbit IgG HRP conjugated secondary antibody (Santa
Cruz) and developed using enhanced chemiluminescence
detection (Pierce Biotechnology, Rockford, IL, USA).
Experiments were performed twice using different cell
extracts. Band densitometry was performed using AdobeBMC Cancer 2008, 8:280 http://www.biomedcentral.com/1471-2407/8/280
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Photoshop CS3 Extended version 10.0 software (Adobe
Systems Incorporated).
Colony formation assay
The ability of Daoy cells to grow in soft agar was analyzed
as described [21]. Briefly, 60 mm soft agar plates contain-
ing 10% FBS (Atlanta Biologicals) MEM (Invitrogen) and
0.4% agar noble (BD Biosciences, San Jose, CA, USA) were
inoculated with a suspension of 3 × 103 cells of either con-
trol or Msi1 knockdown Daoy. Cells were fed once a week
by adding 0.5 ml of complete IMEM medium (Invitro-
gen). After 8 weeks of incubation, colonies were stained
over night with 1 mg/mL p-iodonitrotetrazolium solution
(Sigma) and scored using the colony counting application
from the Quantity One software (Bio-Rad). Three individ-
ual clones were tested with each sample analyzed in quad-
ruplicate. Two independent experiments were performed
with similar results.
Neurosphere culture assay
Daoy neurosphere culture was performed as described
[46] Briefly, cells were trypsinized and washed in Neuro-
basal medium (Invitrogen) and resuspended at 5 × 104
cells/mL in the same medium containing 2 mM L-
glutamine, N2 supplement, B27 supplement, 20 ng/mL
hrEGF, 20 ng/mL hrbFGF and 50 μg/mL BSA (Invitrogen).
1  μg/mL of puromycin (InvivoGen) was included to
ensure shRNA plasmid selection. Fresh growth factors
were added to the cells twice a week. Neurospheres were
disaggregated in single-cell suspensions and reseeded at
clonal density as described [46] to form secondary, terti-
ary and quaternary spheres. For the neurosphere dilution
assay single-cell suspensions of control and Msi1 knock-
down Daoy cells were plated in Neurobasal medium in
96-well plates (serial dilutions from 1000 to 1 cell/well).
After 10 days incubation the number of spheres larger
than 50 μm in diameter were quantified in 8 wells. Two
independent experiments were performed with similar
results.
Quantitative RT-PCR
RNA was prepared using Trizol reagent (Invitrogen),
treated with RNase-free DNaseI (Roche Diagnostics, Indi-
anapolis, IN, USA) as per manufacturer's protocols and
tested by PCR to ensure the absence of genomic DNA con-
tamination. Gene specific primers for real-time RT-PCR,
listed in Additional file 1, were designed using Primer3
[47] and purchased from Integrated DNA Technologies
(IDT, Coralville, IA, USA). One-step RT-PCR reactions
were performed using an ABI 7500 real time PCR system
(Applied Biosystems, Foster City, CA, USA) following
manufacturer's instructions. Briefly, 50 ng total RNA was
reverse transcribed at 48°C for 45 min using 150 nM gene
specific primers, 0.5 U/μL of MultiScribe Reverse Tran-
scriptase and 0.4 U/μL of RNase Inhibitor in 1× SYBR
Green PCR Power Master Mix (ABI). RT enzyme was heat
inactivated at 95°C for 10 min and PCR was carried out as
follows: One cycle of 95°C for 5 min and 40 cycles of 15
s at 95°C followed by 1 min at 50–60°C according to
primers' Tm. Relative gene expression was determined
using the comparative CT method and the ABI 7500 Prism
Software. 15S RNA levels were used as endogenous con-
trol for normalization. Specificity of PCR amplification
was confirmed by the dissociation curves of the ampli-
cons. Samples were analyzed in quadruplicate using two
different RNA preparations.
Hedgehog pathway blockade
Cyclopamine and its analog tomatidine were purchased
from Calbiochem (San Diego, CA, USA) and stocked as 5
mM solution in 95% ethanol. Both drugs were used at a
concentration range of 5–20 μM in Neurobasal medium
prepared as described above. Briefly, neurospheres were
dissociated as described [46] and single-cell suspensions
reseeded at clonal density in 12-well plates (10,000 cells/
well). The effects of Hedgehog blockade upon sphere for-
mation in Daoy control and knockdown cells were evalu-
ated after 7 days of incubation. Two experiments were
performed with similar results.
Statistical analysis
Statistical analysis was performed using GraphPad
(GraphPad Software, Inc., San Diego, CA, USA). Data
from quantitative RT-PCR, soft agar growth and SP is pre-
sented as means ± standard error (se), and were analyzed
by two-tailed unpaired Student's t-test. Differences were
considered significant when P-value was below 0.05.
Results
Msi1 expression in Daoy neurosphere cultures
To determine if Msi1 might play a role in Daoy cancer cell
proliferation, we measured the levels of MSI1 mRNA in
Daoy neurosphere cultures by quantitative RT-PCR (Fig-
ure 1). On average, a 2-fold increase in MSI1 level was
detected in neurospheres (actively proliferating culture)
compared to monolayers (less actively proliferating cul-
ture). Since neurosphere cultures can be enriched in
tumor re-initiating cells and Msi1 is a stem cell marker
with a role in cell cycle progression [13], the higher level
of Msi1 detected in neurospheres indicated that Msi1 may
contribute to Daoy cancer cell proliferation.
Generation of a Msi1 knockdown in the medulloblastoma 
cell line Daoy
We depleted Msi1 in the medulloblastoma cell line Daoy
using a vector-based siRNA which targeted a sequence
unique for Msi1 located in the 3'UTR of the gene. As a neg-
ative control, cells were transfected with the same vector
containing a non silencing shRNA (Open Biosystems,
Inc., Huntsville AL, USA). Three individual clones exhib-BMC Cancer 2008, 8:280 http://www.biomedcentral.com/1471-2407/8/280
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iting at least a 70% knockdown efficiency at the mRNA
level (determined by quantitative RT-PCR; Additional file
1) were selected. Msi1 protein knockdown was confirmed
by western blot (Additional file 1) using a polyclonal anti-
body generated in our laboratory.
Msi1 knockdown impaired anchorage-independent growth 
in Daoy cell line
We analyzed the effect of Msi1 on anchorage-independent
growth (clonogenicity) in Daoy cells as an in vitro assay for
tumorigenicity. Colony formation assays were performed
in soft agar as previously described [21]. As shown in Fig-
ure 2, Msi1 knockdown reduced the ability of Daoy cells
to form colonies in soft agar by 3 to 4-fold thus indicating
that Msi1 promoted cell proliferation in these cancer cells
and, consequently, that might play a role in tumor
growth.
Msi1 sustained cancer cells
Msi1 is a stem cell marker reported to be essential for
maintenance of stem cells [1,3,4]. Cells with stem-like
properties have been isolated in many human brain can-
cers including medulloblastoma (reviewed in [22]). Since
high levels of Msi1 are frequently found in medulloblast-
oma and since we observed that Msi1 expression was ele-
vated in Daoy neurosphere compared to monolayer
cultures (Figure 1), we asked if Msi1 might be involved in
regulating proliferation in cancer cells. Here we evaluated
neurosphere formation as an indicator of cell proliferative
potential. Single-cell suspensions were plated at clonal
density to minimize the effects of cell aggregation in favor
of single-cell sphere generation. After 10 days of incuba-
tion, neurospheres larger than 50 μm in diameter were
counted. As shown in Figure 3, a significant reduction in
both number and overall size of the spheres was detected
when Msi1 expression was depleted. The defect observed
in sphere formation was more severe in subsequent serial
passages (data not shown), thus indicating a role for Msi1
in sustaining cancer cells.
Msi1 regulates expression of Notch, Hedgehog and Wnt 
components
Msi1 represses translation of NUMB [12], which antago-
nizes the activity of Notch and Hedgehog [18,19].
Recently, it has been shown that Msi1 also activates Notch
and Wnt in mammary progenitors through an autocrine
mechanism involving up-regulation of Proliferin-1 and
down-regulation of Dickkopf-3 [23]. Notch, Hedgehog
and Wnt pathways are central regulators of cell prolifera-
tion and their deregulation is frequently associated with
medulloblastoma (reviewed in [22]). With the high levels
of Msi1 reported for medulloblastoma, a connection
among Msi1, Notch, Hedgehog and Wnt activities and
tumor growth is likely. To investigate if Msi1 was modu-
lating the activity of these pathways in Daoy, the expres-
sion of some Notch, Hedgehog and Wnt pathway
components and downstream targets were evaluated by
quantitative RT-PCR. The primers used for this analysis
are listed in Additional file 1. In the knockdown, up-regu-
lation of the Wnt inhibitor Dickkopf-1 (DKK1; >70%
increase) was observed along with a down-regulation in
the Wnt downstream target FOS  (60% reduction) as
shown in Figure 4. Down-regulation of a subset of Notch
and Hedgehog related genes was also found. In this
regard, lower levels of the Hedgehog component SMO
(50% decrease) and of the downstream targets MYCN
(90% decrease), CCND2,  PPAP2B  and  CDKN1A  (50%
decrease) were detected in the Msi1 knockdown cells
together with lower levels of the relevant Notch compo-
nent NOTCH2 (40% decrease) and of the downstream
target HEY2 (60% decrease). Intriguingly, up-regulation
of the Wnt and Hedgehog common downstream target
CCND1 (>60% increase) was observed. Overall it seemed
that Msi1 modulates expression of a number of genes
involved in cell proliferation, differentiation and survival
processes. Therefore, our observation was in agreement
with Wang et al recent findings using mammary progeni-
tors [23].
Msi1 knockdown potentiated the effects of Hedgehog 
blockade
To determine the relevance of Hedgehog in cell prolifera-
tion in our model system, we performed a neurosphere
assay in the presence of different concentrations of
cyclopamine. Cyclopamine is a plant alkaloid which
antagonizes Smoothened (Smo), a major signal trans-
ducer of the Hedgehog pathway [24]. As a negative con-
Msi1 expression in Daoy neurospheres Figure 1
Msi1 expression in Daoy neurospheres. The levels of 
MSI1 RNA levels were analyzed in Daoy cells grown as mon-
olayer (nonNSC) and as neurosphere (NSC) cultures using 
quantitative RT-PCR. GAPDH and 15S mRNA levels were 
used as endogenous control for normalization. On average, a 
2-fold increase in MSI1 was detected in the neurosphere cul-
tures.* indicate p < 0.01.BMC Cancer 2008, 8:280 http://www.biomedcentral.com/1471-2407/8/280
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trol, we used the structural analog tomatidine at the same
concentrations. While 5 μM cyclopamine induced a
marked reduction in neurosphere size in the Msi1 knock-
down cells (p < 0.05), 4 times higher concentrations were
needed to elicit a significant effect in the control Daoy
cells (p < 0.01; Figure 5). Therefore, Hedgehog seems to be
important for neurosphere formation in Daoy cells, and
the increased susceptibility to cyclopamine observed for
Msi1 KD cells may reflect a partial down-regulation in the
activity of this pathway.
Msi1 potential implication in cell differentiation and 
apoptosis
In order to determine Msi1's possible involvement in cell
differentiation and apoptosis we analyzed the levels of the
neural marker βIII Tubulin and the antiapoptotic protein
Bcl2 by western blot in the cell line Daoy (Figure 6). On
average, a 5-fold increase (p < 0.05) in βIII Tubulin and a
8-fold decrease (p < 0.05) in Bcl-2 were detected when
Msi1 was knocked down. The higher levels of βIII Tubulin
detected in the knockdown indicated that Msi1 arrests cell
Anchorage-independent growth Figure 2
Anchorage-independent growth. The effect of Msi1 expression upon anchorage-independent growth was studied as an in 
vitro indicator of tumorigenicity in Daoy cells. Two independent experiments were performed with similar results. Msi1 deple-
tion reduced the ability to form colonies in soft agar by 3 to 4-fold which indicated that Msi1 may sustain the malignant poten-
tial of this tumor cell line. a) A representative image of the colonies formed by the control and knockdown (KD) cell lines is 
shown. The average results for the three clones (b) and for each individual one (c) are represented. * and ** indicate p < 10-3 
and p < 10-5, respectively, compared to control.
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Neurosphere formation assay Figure 3
Neurosphere formation assay. a) Second generation of neurospheres derived from Daoy control (upper) and knockdown 
(KD; lower) at two different cell densities (500 and 250 cells/well) are shown. The smaller size neurospheres detected in the 
knockdown suggested that Msi1 controls cell proliferation in Daoy. b) The average number of spheres per well is represented 
at different cell densities (500, 250, 125 and 75 cells/well). Only spheres larger than 50 μm in diameter were scored. c) The dif-
ferences in neurosphere size are represented at different cell densities (500, 250, 125 and 75 cells/well). * indicates p < 0.05 
and ** p < 0.0001.BMC Cancer 2008, 8:280 http://www.biomedcentral.com/1471-2407/8/280
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Msi1 downstream effects Figure 4
Msi1 downstream effects. The RNA levels of a subset of Notch, Hedgehog and Wnt pathway components were quantified 
by quantitative RT-PCR in control and knockdown Daoy cells. Gene expression changes are represented (mean ± se) using 
semi-logarithmic scale. The plot in the upper part (a) shows the fold change in mRNA levels for the Msi1 knockdown normal-
ized to the housekeeping gene 15S. The table (b) summarizes the ratio (in percentage) of mRNA levels detected in Msi1 knock-
down vs control. * represents p < 0.05 and ** p < 0.01.BMC Cancer 2008, 8:280 http://www.biomedcentral.com/1471-2407/8/280
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Effect of Hedgehog blockade upon neurosphere formation Figure 5
Effect of Hedgehog blockade upon neurosphere formation. The ability to form neuropheres in the presence of the 
Hedgehog inhibitor cyclopamine was evaluated in Daoy cells. Spheres derived from Daoy control (upper) and Msi1 knockdown 
(KD; lower) were incubated for one week in the presence of inhibitor (Cyc) and tomatidine (Tom; negative control) at a con-
centration range of 5–20 μM. A reduction in neurosphere size was observed in both cell lines; however, the knockdown cell 
line appeared to be more sensitive to cyclopamine treatment as the effects upon sphere formation were significant (p < 0.05) 
at lower concentrations of inhibitor. a) Representative images of the effects upon neurosphere formation at 5 μM and 20 μM 
cyclopamine are shown. Scale bars represent 100 μm. b) The average number of neurospheres per field is represented for con-
trol and KD cells after treatment with tomatidine and cyclopamine. * indicates p < 0.05, ** p < 0.01 and *** p < 0.001.BMC Cancer 2008, 8:280 http://www.biomedcentral.com/1471-2407/8/280
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differentiation. Decline in both Bcl2 protein (Figure 6)
and BCL2 transcript (Figure 4) levels were also detected in
the knockdown suggesting that Msi1 may block apoptosis
in D a o y  c e l l s .  A s  a  m o r e  i m p o r t a n t  r e d u c t i o n  w a s
detected at protein level than at mRNA level (~30%
down-regulation; Figure 4), additional post-trancrip-
tional mechanisms might be mediating the decrease of
Bcl2 protein in our model system. Overall, the results
obtained in our model system are consistent with a
recent report by Dobson et al. [25] which demonstrates
that Msi1 has an inhibitory effect upon oligodendro-
cyte precursor differentiation and apoptosis.
Discussion
Msi1 is an RNA binding protein with an essential role in
maintaining the stem cell state [1,3,4]. High levels of Msi1
have been found in several malignancies, including
medulloblastoma [5,6]. As Msi1 expression was elevated
in Daoy neurospheres (Figure 1), we asked if Msi1 may
promote expansion of cancer cells. In this study, we used
the cell line Daoy as our model system. Daoy is a well-
characterized cell line, which among other features,
expresses elevated levels of Msi1 [5], is able to form colo-
nies in soft agar and neurospheres when cultured in the
presence of growth factors, has functional Notch, Hedge-
hog and Wnt signaling pathways and is tumorigenic in
nude  mice [26-28]. We performed a shRNA mediated
knockdown of Msi1 in Daoy and found that cancer cells
expressing low levels of Msi1 were less clonogenic (prolif-
eration assay), more differentiated (higher βIII Tubulin
expression) and, possibly, more apoptotic (lower Bcl2
expression). We also observed a defect in neurosphere for-
mation which was consistent with a potential role of Msi1
in activating proliferation and/or preventing differentia-
tion and apoptosis in Daoy cells. Taken together, our data
suggest that Msi1 may contribute to the proliferation of
cancer cells. This observation was in agreement with pre-
vious reports correlating high levels of Msi1 with glioma
and astrocytoma malignancy [8,9].
Notch, Hedgehog, Wnt and p53 are important pathways
that are frequently found to be deregulated in cancer
(reviewed in [14-17]). Msi1 represses translation of numb
[12]; an antagonist of Notch and Hedgehog signaling
pathways [18,19] which also prevents degradation of the
tumor suppressor p53 [20]. Msi1 also activates Wnt path-
way through an autocrine mechanism [23]. Thus it is pos-
sible that high levels of Msi1 may deregulate Notch,
Hedgehog, Wnt and p53 activities in cancer cells thereby
contributing to tumor growth.
We performed gene expression analysis to determine the
downstream effects derived from Msi1 depletion. Since
Daoy is p53 defective, the effects detected in cell prolifer-
ation in our model system are therefore independent of
p53. However, given that p53 inactivation is found in
50% of the malignancies (reviewed in [17]), an in-depth
work to elucidate the possible effects of Msi1 upon p53
activity in cancer cells is highly desirable.
We demonstrated that Msi1 regulates the expression of
several genes involved in cell proliferation and tumori-
genicity such us MYCN,  SMO,  NOTCH2,  CCND1,
CCND2,  CDKN1A,  FOS,  GLI1, and DKK1  [26,29-36].
Noteworthy was the differential expression of two cell
cycle regulators: CDKN1A  (encoding p21WAF) and
CCND1  (encoding Cyclin D1). A 2-fold decrease was
found in CDKN1A  levels when Msi1 was depleted in
Daoy, possibly due to a reduced Hedgehog activity. Bat-
telli et al. [13] reported that over-expression of Msi1 in
HEK293 activates cell proliferation by down-regulating
p21WAF  protein levels. Using a knockdown model in
Daoy, we showed that Msi1 increases p21WAF transcrip-
tion, possibly, via Hedgehog activation. Although found
in different model systems, it seems that Msi1 may play a
dual role in regulating p21WAF; positive and indirect at the
level of transcription (as shown here) and negative and
direct at the post-transcriptional level (as previously
reported [13]).
Cell differentiation and apoptosis Figure 6
Cell differentiation and apoptosis. The levels of the neu-
ral marker βIII Tubulin and of the antiapoptotic protein Bcl2 
were analyzed by western blot. The experiment was per-
formed twice using two different cell extracts. a) The higher 
level of βIII Tubulin detected in knockdown (KD) vs control 
(Ctrl) indicates that Msi1 may play a role in inhibiting cell dif-
ferentiation. In addition, the reduced levels of Bcl2 detected 
in the knockdown (b) suggested a potential role for Msi1 in 
preventing apoptosis. c) β-Actin was used as loading control.BMC Cancer 2008, 8:280 http://www.biomedcentral.com/1471-2407/8/280
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The up-regulation of CCND1 detected in the Msi1 knock-
down was intriguing. CCND1 transcription is induced in
response to many oncogenic signals like Ras, ErB2, Src
and Wnt (reviewed in [37]) and CyclinD1 overexpression
is associated with tumorigenesis and metastasis. Moreo-
ver, CCND1 expression is considered an early event in
malignancy and its loss inhibits tumor formation in a
Ptch1+/- mouse model [38]. On the other hand and in
agreement with our observation, down-regulation of
CCND1 has recently been reported by Rubio et al. during
spontaneous mesenchymal cell transformation [39].
Therefore, the mechanism driving up-regulation of
CCND1 and its biological implications in our knockdown
model system would justify a more intense investigation.
Cross-talk within Notch, Hedgehog and Wnt pathways
has often been reported [5,23,26,31,40-42] indicating
that the activity of these pathways needs to be fine-tuned
in order to maintain homeostasis. We observed that Msi1
regulated the expression of Hedgehog key components,
including the pathway mediators SMO and GLI1 and the
pathway downstream target MYCN, known to control cell
proliferation and tumorigenicity [29,30,34]. Interestingly,
simultaneous expression of MSI1 and MYCN occurs in
clinical specimens http://home.ccr.cancer.gov/oncology/
oncogenomics/, which posits MYCN as an attractive Msi1
downstream effector. Moreover, MYCN  represses tran-
scription of the tumor suppressor DKK1 [43]. We thus
propose that down-regulation of MYCN in Daoy cancer
cells after Msi1 depletion might induce expression of the
Wnt repressor DKK1, therefore interconnecting Msi1, Wnt
and Hedgehog signaling pathways. At least in part, this
Msi1/MycN/Dkk-1 axis may explain the growth suppres-
sive effect observed in our knockdown model system.
To determine the relevance of the Hedgehog pathway in
Daoy cancer cells, we performed a neurosphere culture
assay in the presence of cyclopamine. Cyclopamine inhib-
ited neurosphere formation in both cases; however, the
effects in the knockdown cells were evident at a signifi-
cantly lower concentration of antagonist. This data was
consistent with a partial down-regulation of Hedgehog
activity after Msi1 depletion in Daoy cells. On the other
hand, it does not exclude the possibility that Msi1 may
also modulate the activity of additional cell proliferation
pathways such as Notch or Wnt.
We also found that Msi1 increased NOTCH2 levels thus
suggesting a potential role of Msi1 in contributing to
tumor growth. NOTCH2 is a component of the Notch
pathway that acts as a mitogen for cerebellar granule cell
precursors [44] and whose expression has been associated
with malignancy in brain tumors and with the persistence
of cancer cells [26,27,33]. Indeed, it has been shown that
Notch blockade reduces cancer cells in Daoy and inhibits
tumor engraftment in nude mice [26,27].
Conclusion
In summary, our data suggest that Msi1 modulates prolif-
eration of cancer cells. Msi1 regulated expression of a set
of genes with a well-established role in cell proliferation,
cell differentiation and survival and its loss appeared to
have a detrimental effect on the maintenance of cancer
cells. We thus propose that, by hijacking normal cell sign-
aling pathways, Msi1 may sustain cancer cells. Likely,
Msi1 regulates additional genes and a systems biology
approach needs to be carried out to identify new Msi1
direct targets (i.e. post-transcriptionally regulated genes)
and uncover the gene network controlled by Msi1. We
believe that the identification of additional Msi1 direct
target genes is necessary to better understand the function
of this RNA binding protein in cancer cells. These insights
may provide a foundation for designing novel and more
rational therapies.
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